# LUCIGEN CORP: Form D filings

LUCIGEN CORP, a biotechnology company in Middleton, WI, filed 4 Form D notices with the SEC between 2012 and 2015. The latest, on March 17, 2015, reports $2.2 million sold of a $2.5 million offering to 29 investors.

Find out what LUCIGEN CORP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20LUCIGEN%20CORP%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=LUCIGEN%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Flucigen-corp-1281599)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20LUCIGEN%20CORP%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=LUCIGEN%20CORP&page=%2Fdata%2Fform-d%2Fcompany%2Flucigen-corp-1281599)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Wisconsin](https://specstream.ai/data/form-d/state/wisconsin): 361 rows, by operating companies, filed since November 1, 2024, $18.05, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/wisconsin
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2905 PARMENTER STREET, Middleton, WI, 53562
- Phone: (608) 831-9011
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Wisconsin
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1281599

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 17, 2015 | Amendment | $2,500,000 | $2,225,930 | $274,070 | 29 | Dec 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1281599/000089271215000398/0000892712-15-000398-index.htm) |
| Jan 14, 2015 | New notice | $2,000,000 | $1,950,000 | $50,000 | 1 | Dec 30, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1281599/000089271215000040/0000892712-15-000040-index.htm) |
| Aug 22, 2012 | Amendment | $1,699,919 | $1,699,919 | $0 | 0 | Mar 30, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1281599/000128159912000004/0001281599-12-000004-index.htm) |
| Apr 2, 2012 | New notice | $1,075,000 | $0 | $1,075,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1281599/000128159912000003/0001281599-12-000003-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Julie Mead | Director |  |
| Jeffrey Williams | Executive Officer, Director |  |
| Ralph Kauten | Executive Officer, Director |  |
| David Mead | Executive Officer, Director |  |
| Timothy Konicek | Director |  |
| Christopher Fortune | Director |  |

[Every Form D from the week of Mar 16, 2015](https://specstream.ai/data/form-d/week/2015-03-16) · [All recent filings in Wisconsin](https://specstream.ai/data/form-d/state/wisconsin) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what LUCIGEN CORP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).